Cocrystal Pharma, Inc. earnings releases COCP

Annual Quarterly

Cocrystal Pharma, Inc. last reported quarterly results on Nov 14, 2025, for Q3 FY2025 (the quarter ended Sep 30, 2025): diluted EPS of -$0.19. It usually reports 44–45 days after a quarter ends.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 44–45 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released	Quarter	Revenue	Net income	Diluted EPS
Nov 14, 2025 45 days after quarter end	Q3 FY2025 ended Sep 30, 2025	—	-2 +58.5%	-0.19 +61.2%
Aug 14, 2025 45 days after quarter end	Q2 FY2025 ended Jun 30, 2025	—	-2 +61.5%	-0.20 +62.3%
May 15, 2025 45 days after quarter end	Q1 FY2025 ended Mar 31, 2025	—	-2 +41.8%	-0.23 +41.0%
Nov 13, 2024 44 days after quarter end	Q3 FY2024 ended Sep 30, 2024	—	-5 -18.6%	-0.49 -19.5%
Aug 14, 2024 45 days after quarter end	— ended Jun 30, 2024	—	—	—
May 13, 2024 43 days after quarter end	— ended Mar 31, 2024	—	—	—
Nov 13, 2023 44 days after quarter end	— ended Sep 30, 2023	—	—	—
Aug 16, 2023 47 days after quarter end	— ended Jun 30, 2023	—	—	—

Company profile

Industry: Pharmaceutical Preparations (SIC 2834)
Listed as: COCP (Nasdaq)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: Bothell, WA
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 1412486
Former names: BIOZONE PHARMACEUTICALS, INC. (until Mar 25, 2014); International Surf Resorts, Inc. (until Mar 4, 2011)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.